LMTK3 Antikörper (N-Term)
Kurzübersicht für LMTK3 Antikörper (N-Term) (ABIN5532611)
Target
Alle LMTK3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 156-187, N-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This LMTK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 156-187 amino acids from the N-terminal region of human LMTK3.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
For WB starting dilution is: 1:1000-1,2000
For FACS starting dilution is: 1:10~50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
-
: "Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer." in: Molecular therapy. Oncology, Vol. 32, Issue 3, pp. 200864, (2024) (PubMed).
-
-
- LMTK3 (Lemur Tyrosine Kinase 3 (LMTK3))
-
Andere Bezeichnung
- LMTK3
-
Hintergrund
- The specific function of the protein remains unknown.
-
Molekulargewicht
- 154 kDa
-
Gen-ID
- 114783
-
UniProt
- Q96Q04
Target
-